Literature DB >> 27567835

High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease.

Saeid Taheri1, Jin Yu1, Hong Zhu1, Mark S Kindy1,2.   

Abstract

BACKGROUND: Cerebral ionic homeostasis impairment, especially Ca2+, has been observed in Alzheimer's disease (AD) and also with hypertension. Hypertension and AD both have been implicated in impaired cerebral autoregulation. However, the relationship between the ionic homeostasis impairment in AD and hypertension and cerebral blood flow (CBF) autoregulation is not clear.
OBJECTIVE: To test the hypothesis that a high-salt diet regimen influences the accumulation of amyloid-β (Aβand CBF) and CBF, exacerbates cognitive decline, and increases the propensity to AD.
METHODS: Double transgenic mice harboring the amyloid-β protein precursor (APPswe), and presenilin-1 (PSEN1) along with control littermates, 2 months of age at initiation of special diet, were divided into 4 groups: Group A, APP/PS1 and Group B, controls fed a high-sodium (4.00%) chow diet for 3 months; Group C, APP/PS1 and Group D, controls fed a low-sodium (0.08%) regular chow diet for 3 months. Mean arterial blood pressure (MAP) and CBF were measured noninvasively using the tail MAP measurement device and magnetic resonance imaging, respectively. Aβ plaques numbers in the cortex and hippocampus of APP/PS1 were quantified.
RESULTS: In contrary to controls, APP/PS1 mice fed a high-salt diet did not show markedly elevated mean systolic and diastolic blood pressure (134±4.8 compared with 162±2.8 mmHg, and 114±5.0 compared with 137±20 mmHg, p< 0.0001). However, a high-salt diet increased CBF in both APP/PS1 and controls and did not alter the cerebral tissue integrity. Aβ plaques were significantly reduced in the cortex and hippocampus of mice fed a high-salt diet.
CONCLUSION: These data suggest that a high-salt diet differently affects MAP and CBF in APP/PS1 mice and controls.

Entities:  

Keywords:  Alzheimer’s disease; amyloid-β; blood pressure; cerebral blood flow; cerebral blood volume; magnetic resonance imaging

Mesh:

Substances:

Year:  2016        PMID: 27567835     DOI: 10.3233/JAD-160331

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

Review 1.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Exogenous Short Chain Fatty Acid Effects in APP/PS1 Mice.

Authors:  Diana J Zajac; Benjamin C Shaw; David J Braun; Stefan J Green; Joshua M Morganti; Steven Estus
Journal:  Front Neurosci       Date:  2022-07-04       Impact factor: 5.152

3.  Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study.

Authors:  Bryan J Neth; Akiva Mintz; Christopher Whitlow; Youngkyoo Jung; Kiran Solingapuram Sai; Thomas C Register; Derek Kellar; Samuel N Lockhart; Siobhan Hoscheidt; Joseph Maldjian; Amanda J Heslegrave; Kaj Blennow; Stephen C Cunnane; Christian-Alexandre Castellano; Henrik Zetterberg; Suzanne Craft
Journal:  Neurobiol Aging       Date:  2019-09-26       Impact factor: 4.673

4.  Link Between Dietary Sodium Intake, Cognitive Function, and Dementia Risk in Middle-Aged and Older Adults: A Systematic Review.

Authors:  Devi Mohan; Kwong Hsia Yap; Daniel Reidpath; Yee Chang Soh; Andrea McGrattan; Blossom C M Stephan; Louise Robinson; Nathorn Chaiyakunapruk; Mario Siervo
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.